Latest News and Press Releases

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH...

Horizon Discovery Group plc ("Horizon" or "the Company" or "the Group") Preliminary Results for the Year Ended 31 December 2017 Cambridge, UK, 8 May 2018: Horizon Discovery Group plc...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH...

Horizon Discovery Group plc Horizon Discovery appoints Terry Pizzie as Chief Executive Officer Cambridge, UK, 8 May 2018: Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Group" or...

Horizon Discovery Group plc Horizon Discovery hosts Capital Markets Day today Cambridge, UK, 5 March 2018: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or "the Group"), a global leader...

Horizon Discovery Group plc Capital Markets Day Date Change to 5 March 2018 Cambridge, UK, 20 February 2018: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or "the Group"), a global...

Horizon Discovery Announces Leadership Changes Cambridge, UK, 20 February 2018: Horizon Discovery Group plc (LSE: HZD) ("Horizon", "the Company", or "the Group"), a global leader in gene editing...

Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company Horizon out-licenses proprietary cell line and Helitron transposon gene editing technologies demonstrating...

Horizon Discovery announces inclusion of its Reference Standards in successful FDA approval of an oncology companion diagnostic test with leading next generation sequencing company Horizon's...

Horizon Discovery Group plc ("Horizon" or "the Company") Preliminary Results for the Year Ended 31 December 2016 Revenue of £24.1m in line with guidance Revenue growth of 19% driven by...